A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for Small Cell Lung Cancer
27 locations incl. Daphne
Sponsor: Puma Biotechnology, Inc.
Sex: All·Age: 18+
Code: NCT06095505·Phase 2·Recruiting·Listed Oct 2023
The Oncology Institute of Hope and Innovation
Clinical research site in Fort Lauderdale, Florida
Part of Oncology Institute of Hope and Innovation
As of July 2026, 2 paid clinical trials are recruiting at The Oncology Institute of Hope and Innovation in Fort Lauderdale, Florida. Active studies at this site cover conditions such as NSCLC Stage IV and Small Cell Lung Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at The Oncology Institute of Hope and Innovation (2)
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
for NSCLC Stage IV
19 locations incl. Springdale
Sponsor: ImmunityBio, Inc.
Sex: All·Age: 18 - 90
Code: NCT06745908·Phase 3·Recruiting·Listed Dec 2024
More research sites in Fort Lauderdale
- Holy Cross Hospital (42 trials)
- Broward Health Medical Center (23 trials)
- Nova Southeastern University (8 trials)
- Holy Cross Health (3 trials)
- Proactive Clinical Research (3 trials)
- Retina Group of Florida (3 trials)
- The Center for Diabetes and Endocrine Care (3 trials)
- Broward Health (2 trials)
- Center for Skin Science and Innovation (2 trials)
- Florida Kidney Physicians, LLC - Fort Lauderdale (2 trials)
Explore more
Paid clinical trials in Fort Lauderdale, FL · Florida clinical trials